Yiqiao Yin | Seeing Deep into the Lungs with Deep Learning
X-rays and other forms of medical imaging let doctors peer into the body, revealing the internal structure of organs and tissues without invasive surgery. Doctors use the results to identify abnormalities such as broken bones, diagnose diseases such as cancer, or even monitor the health of a foetus within the womb. Although this technology is remarkable, the images aren’t useful in isolation. Experts must analyse the resulting data and parse what is healthy or unhealthy from the noise. Yiqiao Yin, Jaiden Schraut, Leon Liu and Jonathan Gong have created new machine learning technologies to support that crucial interpretation, focusing on X-rays and lung health.
A Window into the Body
By 2010, over 5 billion medical imaging studies had been conducted, including X-ray images revealing the shapes of bone fractures, the presence of breast tumours, the location of kidney stones, the health of the lungs, and much more.
Skin, muscle, bone – and just about every part of your body – is opaque to visible light. This means that these tissues absorb light with wavelengths of between 380 and 700 nanometres: the visible part of the electromagnetic spectrum. However, if we go down to light with wavelengths of just 10 nanometres and below, we find X-rays. The lower the wavelength of light, the more energy it contains, and so X-rays carry much more energy than visible light.
These X-rays tend to pass straight through soft tissues, barely interacting with them, just as visible light passes through glass. However, harder tissues contain heavier elements such as calcium, which can absorb X-rays. This means X-rays will pass through soft tissue, but bones, teeth and other hard tissues will be opaque, blocking X-rays just as your hand blocks visible light.
Decoding the Images
X-ray imaging makes it easy to spot a broken bone, and even to diagnose what kind of fracture has occurred – is it a partial hairline fracture, or a break all the way through? However, not all uses of X-rays are as simple as spotting cracks in bone.
Yiqiao Yin and his colleagues, Jaiden Schraut, Leon Liu and Jonathan Gong, focus on chest X-rays for lung health, which require careful interpretation. Machine learning can support this interpretation by automating some aspects of the data processing, but this requires a delicately constructed artificial intelligence system, as well as the trust of both the doctor and patient.
Yin and his colleagues have developed new cutting-edge algorithms to process the raw data for doctors, while providing them with more context and additional information than existing solutions.
While X-rays of broken bones tend to be 2D images, in more complex health issues, multiple images can be stitched together to create a 3D representation. This process gives more detail, and allows doctors to navigate the 3D space to make more precise conclusions. However, this can mean that it is even more complex to make those conclusions.
One important step is segmentation, in which the pixels of the images are divided according to their brightness, texture, colour, or other criteria. This can be done manually by radiologists, but this is incredibly time-consuming, and introduces the potential for human error in interpreting the data.
This is especially challenging in the lungs, which evolved to be incredibly complex to maximise surface area for gas exchange. This means that, for example, it can be difficult to distinguish the damage done to the lungs by pneumonia versus COVID-19, which each have different treatments. Recent research has produced models that can automate the process of segmentation, and Yin’s team has further developed this approach by building a hybrid model that both segments and classifies the data.
Inside the Algorithm
Neural networks have become a popular tool for processing lung scans. These are a powerful class of algorithms that are inspired by the structure of the brain, consisting of ‘neurons’ and connections between those neurons. You can input data in one end of the network, and it will flow through to an output layer, just as information enters your eye and travels through the neurons in your brain. This processes the raw data, generating the image we see in our mind.
However, each connection must be fine-tuned for the model to work. This is hugely complex, and can’t be done manually. Instead, Yin and his colleagues trained and tested their neural network using the data and results from 21,165 chest X-ray images.
Ironically in this case, a perennial drawback of neural networks is their lack of transparency. They provide incredibly accurate results, but it is almost impossible to figure out exactly how they came to that conclusion. Yin and his team tackled this by combining the classification and segmentation processes.
While one part of their model builds a segmented 3D image, another part identifies any pixels or areas that were particularly useful in the neural network’s recommended diagnosis. These can be combined to produce a heatmap on top of the 3D image, automatically highlighting those areas of the lungs that distinguish between different diagnoses.
This means doctors get a recommended classification (for example, the model might recommend a diagnosis of pneumonia induced lung cancer), while also presenting a 3D heatmap for them to explore. This boosts the trust in the model, since doctors can see the underlying data displayed clearly, and patients can be lead through an explanation of how the conclusion was reached, and where exactly the problems lie.
The team tested their final model using more real-life examples from the COVID-19 Radiography database, and their final model achieved an accuracy of 95%, meaning 19 out of 20 of their diagnoses matched the data. This is a remarkable achievement, and provides doctors with an excellent tool to interpret and explain the diagnosis.
Improving Medical Diagnostics
The more accurately we can diagnose patients’ diseases, the more effective our treatments are. For instance, distinguishing bacterial pneumonia from COVID-19 is the difference between a simple course of antibiotics and two weeks of worsening symptoms.
Furthermore, although this combination of automated segmentation and classification is relatively novel, this approach isn’t restricted to just chest X-rays: it could be applied to many essential medical exams, such as CT scans to diagnose thyroid cancer, MRI to identify stroke in the brain, ultrasound to measure the health of a foetus, and many others.
The more we improve our non-invasive scanning technologies, the more patients can be spared mis-diagnoses, delays, or even exploratory surgery, all of which can cause unnecessary harm. Yin’s technology advances our ability to image, diagnose, and ultimately ensure patients receive the treatment they need.
SHARE
DOWNLOAD E-BOOK
REFERENCE
https://doi.org/10.33548/SCIENTIA849
MEET THE RESEARCHER
Yiqiao Yin
Senior Data Scientist
LabCorp
Princeton, NJ
USA
Yiqiao Yin studied machine learning and applied statistics at Columbia University, obtaining an MA in 2019 for his work on predicting relapse in breast cancer patients, achieving an accuracy of 92% compared to the industry standard of 60–70%. In 2020, Yin became a data scientist at Bayer Crop Science in New York, designing and prototyping new algorithms and techniques for the Harvest Analytic Division. Since 2020, Yin has also worked part-time as the Head of Curriculum Development at Veritas AI in New York, developing e-learning and interactive teaching materials for a pre-college AI program. This year, he joined LabCorp in New Jersey, leading projects that tackle drug development AI challenges using tools such as convolutional neural networks, long-short term memory, and recurrent neural networks. He’s worked on technologies that assist pathologists and radiologists with prognoses, and continues to develop state-of-the-art tools that help deliver safe and effective healthcare.
CONTACT
E: Eagle0504@Gmail.com
W: https://www.yiqiao-yin.com/
KEY COLLABORATORS
Jaiden Schraut
Leon Liu
Jonathan Gong
FURTHER READING
JX Shraut, L Liu, J Gong, Y Yin, A multi-output network with U-net enhanced class activation map and robust classification performance for medical imaging analysis, Discover Artificial Intelligence, 2023, 3, 1. https://doi.org/10.1007/s44163-022-00045-1
REPUBLISH OUR ARTICLES
We encourage all formats of sharing and republishing of our articles. Whether you want to host on your website, publication or blog, we welcome this. Find out more
Creative Commons Licence (CC BY 4.0)
This work is licensed under a Creative Commons Attribution 4.0 International License.
What does this mean?
Share: You can copy and redistribute the material in any medium or format
Adapt: You can change, and build upon the material for any purpose, even commercially.
Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
SUBSCRIBE NOW
Follow Us
MORE ARTICLES YOU MAY LIKE
Dr Chi-Huey Wong | Glycoengineering for a Universal COVID-19 Vaccine
The SARS-CoV2 surface spike protein is a rational target for COVID-19 vaccination. However, spike protein glycosylation helps the virus evade the immune system, undermining vaccination efforts against newer variants. Dr Chi-Huey Wong’s group at Academia Sinica, Taiwan, is hoping to combat this by glycoengineering protein- and mRNA-based COVID-19 vaccines.
Dr Amy Shachter | Indigenous Knowledges, Encouragements, Engagements, and Experiences in STEM
Despite efforts aimed at diversifying Science, Technology, Engineering, and Mathematics (STEM) fields, Indigenous communities remain widely underrepresented. The Indigenous Knowledges, Encouragements, Engagements and Experiences (ʻIKE) Alliance is comprised of a group of educators and Indigenous leaders from across the USA who support and facilitate the participation of Native American, Alaska Native, Native Hawaiian, and Pacific Islander (NANA-NHPI) students in STEM. ʻIKE also seeks to strengthen relationships between Indigenous communities and STEM higher education institutions.
Dr Carolyn Fallahi | Stress and Substance Use: The Impact of COVID-19 on Sexual Minorities
Sexual minorities face unique challenges that can negatively impact their mental and physical health. The COVID-19 pandemic has exacerbated these issues, leading to increased rates of anxiety, depression, and substance use among lesbian, gay, bisexual, transgender, and queer (LGBTQ+) individuals. Dr Carolyn Fallahi and her colleagues at Central Connecticut State University have been studying the effects of minority stress on sexual minorities, particularly in the context of the pandemic. Their research sheds light on the complex relationships between minority stress, mental health symptoms, and substance use in this vulnerable population.
Dr Nadine Abi-Jaoudeh | New Hope for the Improvement of Liver Cancer Treatment: A Novel Platform for Drug Delivery
Dr Nadine Abi-Jaoudeh and Dr David Imagawa of the University of California Irvine are working with a team of researchers dedicated to improving treatment options and outcomes in hepatocellular carcinoma – a serious form of cancer associated with long-term liver diseases. Their early-stage research offers important hope that in the future, effective drugs such as sorafenib and regorafenib may be utilised in trans-arterial chemoembolisation thanks to their development of a novel platform for drug delivery.